Full View

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

JJ Carlson, WB Wong, DL Veenstra… - Journal of Medical …, 2011 - Taylor & Francis
Objective: Assess the budgetary impact of adding erlotinib for maintenance therapy (MTx) in
advanced non-small cell lung cancer (NSCLC) from a US health plan perspective. Methods …
被引用次数：15 相关文章

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

JJ Carlson, WB Wong… - Journal of medical …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective Assess the budgetary impact of adding erlotinib for maintenance therapy (MTx) in
advanced non-small cell lung cancer (NSCLC) from a US health plan perspective. Methods …

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer.

JJ Carlson, WB Wong, DL Veenstra… - Journal of Medical …, 2011 - europepmc.org
Objective Assess the budgetary impact of adding erlotinib for maintenance therapy (MTx) in
advanced non-small cell lung cancer (NSCLC) from a US health plan perspective. Methods …